{"id":"https://openalex.org/W7095465835","doi":null,"title":"Tamoxifen: A Novel Approach for the Treatment of Estrogen Receptor Negative Cancers","display_name":"Tamoxifen: A Novel Approach for the Treatment of Estrogen Receptor Negative Cancers","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7095465835"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.302.2135","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.302.2135","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ijser.org/researchpaper/Tamoxifen-A-Novel-Approach-for-the-Treatment-of-Estrogen-Receptor-Negative-Cancers.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7095465835"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Eun Be Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eun Be Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Judith Jacobson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith Jacobson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Donna Leonardi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Donna Leonardi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.03139999881386757,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":1.0},{"id":"https://openalex.org/keywords/protein-kinase-c","display_name":"protein kinase C","score":0.7730000019073486},{"id":"https://openalex.org/keywords/mtor","display_name":"mTOR","score":0.8429999947547913},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.8420000076293945},{"id":"https://openalex.org/keywords/burkitt-lymphoma","display_name":"Burkitt lymphoma","score":0.8510000109672546},{"id":"https://openalex.org/keywords/ramos-cells","display_name":"Ramos cells","score":0.8050000071525574},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.7459999918937683},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-modulators","display_name":"selective estrogen receptor modulators","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8604999780654907},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.7353000044822693},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6358000040054321},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5827000141143799},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5102999806404114},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.5097000002861023},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.4625000059604645},{"id":"https://openalex.org/C2776067312","wikidata":"https://www.wikidata.org/wiki/Q50429983","display_name":"Antiestrogen","level":5,"score":0.4526999890804291},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.4489000141620636},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4348999857902527},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4205999970436096},{"id":"https://openalex.org/C172313692","wikidata":"https://www.wikidata.org/wiki/Q14902310","display_name":"Estrogen receptor alpha","level":5,"score":0.3993000090122223},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.39660000801086426},{"id":"https://openalex.org/C96307122","wikidata":"https://www.wikidata.org/wiki/Q15329133","display_name":"Estrogen receptor beta","level":5,"score":0.3882000148296356},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38179999589920044},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.37959998846054077},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3702000081539154},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3637000024318695},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.3603000044822693},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3472999930381775},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.34389999508857727},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33899998664855957},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32749998569488525},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3206999897956848},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3142000138759613},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.29750001430511475},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.29679998755455017},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.257099986076355},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.25279998779296875}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.302.2135","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.302.2135","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ijser.org/researchpaper/Tamoxifen-A-Novel-Approach-for-the-Treatment-of-Estrogen-Receptor-Negative-Cancers.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2086383194","https://openalex.org/W2338383776","https://openalex.org/W2148188193","https://openalex.org/W2017487001","https://openalex.org/W1985790561","https://openalex.org/W7014836755","https://openalex.org/W2109202868","https://openalex.org/W2100506877","https://openalex.org/W2158545959"],"abstract_inverted_index":{"Abstract-Tamoxifen":[0],"is":[1,8],"a":[2,47,81,111,160,176,188],"selective":[3],"estrogen":[4,12,22,27,104],"receptor":[5,13,23,105],"modulator":[6],"that":[7,39,49,83,145,186],"used":[9,121,133],"to":[10,95,122,134],"treat":[11],"positive":[14,182],"cancers,":[15,183],"specifically":[16,110],"breast":[17],"cancer.":[18],"Tamoxifen":[19,170],"antagonizes":[20],"the":[21,51,64,67,72,97],"and":[24,87,127,151],"thus":[25],"impedes":[26],"induced":[28],"growth":[29],"of":[30,66,71,91,100,125],"cancer":[31],"cells.":[32],"How":[33],"ever,":[34],"recent":[35],"studies":[36],"have":[37,173,187],"shown":[38],"tamoxifen":[40,101,140,167],"also":[41],"inhibits":[42],"protein":[43,48,82],"kinase":[44],"C":[45],"(PKC),":[46],"activates":[50],"PKC":[52,73,126,149],"/":[53,55,74,76],"Akt":[54,75],"PI3k":[56,77],"pathw":[57,78,192],"ay.":[58,193],"Disrupting":[59],"this":[60,92],"pathway":[61],"results":[62],"in":[63],"inhibition":[65],"dow":[68],"nstream":[69],"target":[70],"ay,":[79],"mTOR,":[80],"promotes":[84],"cell":[85,108,114,137,147],"survival":[86],"growth.":[88],"The":[89,129],"aim":[90],"project":[93],"was":[94,132],"determine":[96],"inhibitory":[98],"activity":[99,153],"on":[102],"an":[103],"negative":[106],"(ER-)":[107],"line,":[109,115],"Burkitt\u2018s":[112],"lymphoma":[113],"Ramos.":[116],"Enzyme":[117],"immunosorbent":[118],"assays":[119],"were":[120],"measure":[123,135],"activities":[124],"mTOR.":[128],"MTS":[130],"assay":[131],"Ramos":[136,146],"viability":[138],"after":[139,166],"treatment":[141,168,177],"(1-25\u03bcM).":[142,169],"Results":[143],"showed":[144],"viability,":[148],"activity,":[150],"mTOR":[152],"each":[154],"decreased":[155],"with":[156],"statistical":[157],"significance":[158],"demonstrating":[159],"dose-response":[161],"relationship":[162],"(p":[163],"<":[164],"0.05)":[165],"may":[171],"therefore":[172],"potential":[174],"as":[175],"for":[178],"not":[179],"just":[180],"ER":[181],"but":[184],"cancers":[185],"constitutively":[189],"activated":[190],"PKC/PI3k/Akt":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7095465835","counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-27T00:00:00"}
